Drug-Eluting Balloons or Stents for Bare-Metal Stent Restenosis

Affiliations

¹ Deutsches Herzzentrum München, Munich, Germany.
² Deutsches Herzzentrum München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. Electronic address: kastrati@dhm.mhn.de.

Free article

Editorial

Jens Wiebe et al. JACC Cardiovasc Interv. 2016.

Free article

. 2016 Jun 27;9(12):1256-1258.

doi: 10.1016/j.jcin.2016.05.007. Epub 2016 Jun 20.

¹ Deutsches Herzzentrum München, Munich, Germany.
² Deutsches Herzzentrum München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. Electronic address: kastrati@dhm.mhn.de.

No abstract available

Keywords: bare-metal stent restenosis; drug-eluting balloon(s); drug-eluting stent(s); in-stent restenosis.

Comment on

Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.
Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, Otaegui I, Masotti M, Zueco J, Veláquez M, Sanchís J, García-Touchard A, Lázaro-García R, Moreu J, Bethencourt A, Cuesta J, Rivero F, Cárdenas A, Gonzalo N, Jiménez-Quevedo P, Fernández C; RIBS V Study Investigators. Alfonso F, et al. JACC Cardiovasc Interv. 2016 Jun 27;9(12):1246-1255. doi: 10.1016/j.jcin.2016.03.037. Epub 2016 Jun 20. JACC Cardiovasc Interv. 2016. PMID: 27339840 Clinical Trial.